Filter by Year
Why This 71-Year-Old Man Living With Cancer Is Cycling Across America
Seventy-one-year-old Chuck Wakefield was diagnosed with multiple myeloma in 2003. Since then the Grapevine, Texas, resident has had a bone-marrow transplant, climbed Mount Kilimanjaro, and is now cycling from Los Angeles, California,…
Read More
 10/26/2017
Cross-Country Cancer Research Ride Cycles Into Fairfield This Weekend
FAIRFIELD, Conn. — A seven-week, coast-to-coast cycling event to raise critical cancer research funds will have its grand finale at Jennings Beach on Saturday. Hundreds of cyclists and supports are…
Read More
 10/20/2017
News Briefs: Cycling event ends in Fairfield, Acting town librarian named…
FAIRFIELD — The grand finale of the Multiple Myeloma Research Foundation’s “Road to Victories” seven-week, coast-to-coast cycling event will culminate on Saturday at Jennings Beach in Fairfield, where hundreds of…
Read More
 10/20/2017
Albany a stop on cyclists’ long trip
Albany welcomed a team of cyclists Tuesday who set out Sept. 3 from Los Angeles on a 3,400-mile ride to raise awareness and funds for critical multiple myeloma research as…
Read More
 10/19/2017
‘Road To Victory’ For Multiple Myeloma Research Ends In Fairfield
FAIRFIELD, Conn. — The grand finale of the Multiple Myeloma Research Foundation’s “Road to Victories” seven-week, coast-to-coast cycling event will culminate  Saturday, Oct 21 at Jennings Beach in Fairfield where…
Read More
 10/19/2017
3,400 Mile Campaign for Multiple Myeloma Passes Through Erie
Road to Victories is a 3,400 mile campaign for multiple myeloma, an incurable form of blood cancer. A team of cyclists traveling thousands of miles across the country for charity…
Read More
 10/13/2017
Cyclists travel cross country for multiple myeloma research
CHAMPAIGN, Ill. (WAND): A team of cyclists took a day off in Champaign this week during cross country bike trip. The group is raising for multiple myeloma, an incurable blood…
Read More
 10/05/2017
Road to Victories makes pit stop in Champaign
CHAMPAIGN, ILL. (WCCU) — A group of cyclists riding across the country to raise awareness for a rare form of blood cancer are made a pit stop in Champaign.
Read More
 10/04/2017
Cyclists ‘tour’ nation for cancer research
A group of bicyclists riding more than 5,000 miles from California to Connecticut, stopped for lunch at Amanda’s Bistro on Tuesday. Taking a break for the rest of the day…
Read More
 09/28/2017
A Road Warrior
Glen Allen resident Jim Hall hits the road to raise awareness of a common, but under-recognized blood cancer Bicycling has long been a passion for Glen Allen resident Jim Hall.…
Read More
 09/28/2017
The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs. Learn more and sign up to receive news and resources from the MMRF.

Learn More

At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.

About Janssen Oncology

Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.

Learn More
Privacy Policy Terms of Use